Europe Next Generation Sequencing (NGS) Market – Industry Trends and Forecast to 2028

  • Healthcare
  • Upcoming Report
  • Dec 2020
  • Europe
  • 150 Pages
  • No of Tables: 30
  • No of Figures: 50

Next Generation Sequencing (NGS) Market, By Product & Service (Pre-Sequencing Products & Services, NGS Consumables, Platforms, & Services for Platforms, Sequencing Services, NGS Data Analysis, Storage, and Management), Technology (Sequencing By Synthesis, Ion Semiconductor Sequencing, Single-Molecule Real-Time Sequencing, Nanopore Sequencing, Other Sequencing Technologies), Application (Diagnostics, Drug Discovery, Agricultural & Animal Research, Other Applications), End-User (Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Other End Users), Country (Germany, U.K., France, Italy, Spain, Switzerland, Netherlands, Belgium, Russia, Turkey Ukraine & Rest of Europe) Industry Trends and Forecast to 2028

Europe Next Generation Sequencing (NGS) Market Market Analysis and Insights : Europe Next Generation Sequencing (NGS) Market

Next generation cancer diagnostics market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to grow at a CAGR of 18.28% in the above-mentioned forecast period. Rising cases of chronic disease such as cancer drives the next generation cancer diagnostics market.

Cancer diagnostics is the type of process detecting numerous biomarkers, proteins and certain symptoms that result in the detection of presence of cancerous tumor in the patients. The process of detecting cancer includes wide usage of certain technology and devices specifically used in its diagnosis.

Rising demand for preventive medicine and companion diagnostics is the vital factor escalating the market growth, also growing cancer incidence and rising levels of geriatric population are the major factors among others driving the next generation cancer diagnostics market. Moreover, technological advancements in the machinery will further create new opportunities for next generation cancer diagnostics market in the forecasted period of 2021-2028.

However, high capital investments, shortage of helium and increased cost of diagnostic imaging systems affecting their rate of adoption in emerging markets are the major factors among others acting as restraints, and will further challenge the growth of next generation cancer diagnostics market in the forecast period mentioned above.

This next generation cancer diagnostics market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research next generation cancer diagnostics market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Next Generation Cancer Diagnostics Market Scope and Market Size

Next generation cancer diagnostics market is segmented on the basis of products and services, technology, application and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • On the basis of products and services, the next generation cancer diagnostics market is segmented into pre-sequencing products and services, NGS consumables, platforms, and services for platforms, sequencing services, NGS data analysis, storage, and management. Pre-sequencing products and services have been further segmented into sample preparation. NGS consumables, platforms, and services for platforms have been further segmented into NGS consumables, NGS platforms and services for NGS platforms. Sequencing Services have been further segmented into exome & targeted re-sequencing and custom panels, RNA-seq, whole-genome sequencing & de novo sequencing and other sequencing services. NGS data analysis, storage, and management has been further segmented into NGS data analysis software & workbenches, NGS data analysis services, NGS storage, management, and cloud computing solutions.
  • Based on technology, the next generation cancer diagnostics market is segmented into sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing, nanopore sequencing and other sequencing technologies.
  • Based on application, the next generation cancer diagnostics market is segmented into diagnostics, drug discovery, agricultural and animal research and other applications. Diagnostics have been further segmented into cancer diagnostics, infectious disease diagnostics, reproductive health diagnostics and other diagnostic applications.
  • Based on end-user, the next generation cancer diagnostics market is segmented into academic institutes and research centers, hospitals and clinics, pharmaceutical and biotechnology companies and other end users.

Next Generation Cancer Diagnostics Market Country Level Analysis

Next generation cancer diagnostics is analysed and market size insights and trends are provided by country, products and services, technology, application and cancer type as referenced above.

The countries covered in the next generation cancer diagnostics market report are Germany, U.K., France, Italy, Spain, Switzerland, Netherlands, Belgium, Russia, and Turkey, Ukraine & Rest of Europe.

The country section of the next generation cancer diagnostics market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of regional brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

Next generation cancer diagnostics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for next generation cancer diagnostics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the next generation cancer diagnostics market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Next Generation Cancer Diagnostics Market Share Analysis

Next generation cancer diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, regional presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to next generation cancer diagnostics market.

The major players covered in the next generation cancer diagnostics market report are Agilent Technologies, Inc., Abbott, BD, bioMérieux SA, NeoGenomics Laboratories, Inc., Telerad Tech, F. Hoffmann-La Roche Ltd, General Electric, Hologic Inc., Illumina, Inc., QIAGEN, BioGenex, Siemens Healthcare GmbH, BioNTech Diagnostics GmbH, Thermo Fisher Scientific Inc. and Koninklijke Philips N.V., SciGenom Labs Pvt. Ltd, Takara Bio Inc. and DNA Link, Inc. among other. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Customization Available : Europe Next Generation Sequencing (NGS) Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions